MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ
676.77
+7.58
+1.13%
After Hours: 676.79 +0.02 +0.00% 19:30 10/26 EDT
OPEN
671.46
PREV CLOSE
669.20
HIGH
678.41
LOW
663.61
VOLUME
306.53K
TURNOVER
--
52 WEEK HIGH
684.52
52 WEEK LOW
373.00
MARKET CAP
18.93B
P/E (TTM)
37.52
1D
5D
1M
3M
1Y
5Y
1D
Medpace Holdings Price Target Raised to $670.00/Share From $600.00 by BMO Capital
Dow Jones · 7h ago
Medpace Holdings Is Maintained at Market Perform by BMO Capital
Dow Jones · 7h ago
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $670
Benzinga · 7h ago
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
NASDAQ · 9h ago
Medpace price target raised to $670 from $600 at BMO Capital
TipRanks · 12h ago
Here's Why Medpace (MEDP) is a Strong Growth Stock
NASDAQ · 12h ago
Weekly Report: what happened at MEDP last week (1019-1023)?
Weekly Report · 15h ago
Medpace: Downgrade 'Hold' Revenue Growth Guidance Change And Slightly Lower Backlog Conversion Rate
Seeking Alpha · 1d ago
More
About MEDP
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Webull offers Medpace Holdings Inc stock information, including NASDAQ: MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.